Digital entrepreneur becomes face of Australian charity

News

Author: Geoffrey ChangPublished: 17 June 2015

Prep: Cook: Serves:

After being diagnosed with early onset Parkinson’s at just 35, self-confessed digital media guru Kate Matheson has been appointed National Ambassador for Australian charity, Shake It Up.

Kate, managing director of GLOSS magazine, is keen to raise awareness for young Australians also living with the disease and getting involved with the charity is her way of inspiring others to help find a cure.

She said: “We aren’t victims, we’re strong, amazing people who happen to have a crummy disease, and we want a cure. Young onset Parkinson’s is real and it’s common. It’s not just a disease of older people.

“Parkinson’s is not a disease you choose. It chooses you. And it doesn’t care if you’re trying to raise a family. It cares about what you choose to do after you’re diagnosed.

“What you choose to do with Parkinson’s is going to shape the future of the disease.”

Last Month

Next Month

Go Back

Share this story

Comments

Special reports

Why we should treat this ‘damaging’ study on physiotherapy in Parkinson’s with caution

President of APPDE calls PD REHAB trial “damaging”

These photos could change the way the world sees Parkinson’s forever

The photographer who's giving Parkinson's a 'total makeover'

A better way to assess the impact of Parkinson’s

EPDA experts launch pilot 'quality of life' study

Tear tests could lead to Parkinson’s diagnosis

A study – carried out by researchers from the University of Southern California, Los Angeles, US – has suggested that testing individuals’ tears could provide a cheap way to screen for Parkinson’s. The research found that the tears of those living with Parkinson’s had five times the level of alpha synuclein – a protein molecule that forms toxic clumps and causes nerve damage. It is hoped that the research will lead to early diagnosis of Parkinson’s and help doctors delay the disease. Dr Mark Lew, who led the study, said: “We believe our research is the first to show that tears may be a reliable, inexpensive and non-invasive biological marker of Parkinson’s disease. “And because the Parkinson’s disease process can begin years or decades before symptoms appear, a biological marker like this could be useful in diagnosing, or even treating, the disease earlier.”

€100,000 investment opportunity for central nervous system research

Zcube, a research venture of Italian pharmaceutical company Zambon, has invited researchers, scientists and aspiring entrepreneurs to apply for its third international Open Accelerator programme. The programme – which runs for 12 weeks at the Openzone campus in Milan, Italy – will have a specific focus on the therapeutic areas of the central nervous system and the respiratory system, including rare diseases in these two areas. Upon completing the accelerator, participants will have the chance to win seed investment of up to €100,000 to develop their projects in collaboration with Zambon. Elena Zambon, president of Zambon, said: “Open Accelerator is a fundamental ‘school’ teaching young researchers how to communicate with the business world and venture capitalists and to take their ideas out of the laboratories and let them become effective opportunities to improve patients’ lives.” Submissions for the accelerator programme are open until 30 June 2018.

Parkinson’s disease may link to impaired response of eyes to blue light

A study published in the medical journal ‘Scientific Reports’ suggests that impaired visual responses to blue light may be linked to non-motor symptoms of Parkinson’s. The study, led by a team of Australian researchers, conducted ophthalmological analysis in 17 patients and 12 healthy volunteers to evaluate the retina and overall visual responsiveness to different coloured stimulations. Researchers found that Parkinson’s patients had an impaired pupil response when reacting to blue lights. Researchers concluded that melanopsin dysfunction can “underpin some of the non-motor symptoms observed in Parkinson’s disease”.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
Captcha
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Digital entrepreneur becomes face of Australian charity

News

Author: Geoffrey ChangPublished: 17 June 2015

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Special reports

Why we should treat this ‘damaging’ study on physiotherapy in Parkinson’s with caution

Interviews

These photos could change the way the world sees Parkinson’s forever

Europe

A better way to assess the impact of Parkinson’s

Tear tests could lead to Parkinson’s diagnosis

€100,000 investment opportunity for central nervous system research

Parkinson’s disease may link to impaired response of eyes to blue light

{title}

Subscribe

Digital entrepreneur becomes face of Australian charity

News

Author: Geoffrey ChangPublished: 17 June 2015

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Special reports

Why we should treat this ‘damaging’ study on physiotherapy in Parkinson’s with caution

Interviews

These photos could change the way the world sees Parkinson’s forever

Europe

A better way to assess the impact of Parkinson’s

Tear tests could lead to Parkinson’s diagnosis

€100,000 investment opportunity for central nervous system research

Parkinson’s disease may link to impaired response of eyes to blue light

{title}

Subscribe

Sign in